Healthcare -
Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
CCCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CCCC - C4 Therapeutics, Inc.
45.5 M
LAST VALUE
-48.48%
2 YEAR CAGR
87.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR